C09DB01 • valsartan + amlodipine • Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and calcium channel blockers
The combination of valsartan and amlodipine is used for the treatment of hypertension, particularly in patients who require combination therapy to achieve adequate blood pressure control. Valsartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels and lowers blood pressure by blocking the effects of angiotensin II. Amlodipine is a calcium channel blocker that helps relax the muscles in the walls of blood vessels, improving blood flow.
This combination is administered orally, usually once daily, and the dosage is adjusted based on the patient's response and blood pressure levels. It is important for patients to adhere to the treatment and regularly monitor their blood pressure.
Common side effects include dizziness, peripheral edema, headaches, and fatigue. In rare cases, severe adverse reactions such as severe hypotension, heart failure, or allergic reactions may occur.
The combination of valsartan and amlodipine provides an effective option for managing hypertension, helping to reduce the risk of cardiovascular complications such as myocardial infarction or stroke.
Substance: valsartan + amlodipine
Date of last drug list: 01-07-2013
Commercial code: W51856010
Concentration: 10mg / 160mg
Pharmaceutical form: tablets
Quantity: 98
Product type: original
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.